WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4901 Infant (under 12 months) mortality rate: 372
GDP / capita (US$): 1'1951 Child (under 5 years) mortality rate: 522

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 6'333  6'131  5'933  5'741  5'558  3'939  3'273  2'415 
Births 233  230  226  222  217  159  143  112 
Surviving infants 223  220  216  211  206  149  129  98 
Pop. less than 5 years 1'060  1'034  1'008  985  960  671  605  449 
Pop. less than 15 years 2'733  2'642  2'554  2'470  2'393  1'852  1'523  1'117 
Female 15-49 years 1'546  1'501  1'456  1'412  1'368  897  763  563 

Number of reported case

(Click for retrospective incidence data for Eritrea)
Diphtheria
Japanese encephalitis
Measles 45  194  48  51  82  789 
Mumps 2'350  3'825  2'410  1'585  2'028 
Pertussis 208  91  11  152 
Polio*
Rubella 19  18  354  163  69  39 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 19  17  16  49  11 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Eritrea)
Vaccine year result method % card seen                                                
BCG 2012  100  EPI   94  97  97  97  90  90  61 
DTP1 2012  100  EPI   94  97  97  97  85  90  59 
DTP3 2012  99  EPI   94  94  94  94  85  85  52 
HepB_BD         
HepB3 2012  99  EPI   94  94  94  94  85  85 
Hib3 2012  99  EPI   94  94  94  94  85  85 
JapEnc         
MCV 2012  98  EPI   94  75  77  95  85  80  50 
MCV2         
PCV1         
PCV3         
Pol3 2012  99  EPI   94  94  94  94  85  85  52 
Rota1         
Rota_last         
Rubella1         
TT2plus 2012  97  EPI   94  94  35  35  35  50  25 
PAB         
VAD1          95  95  95  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Eritrea)
BCG 97  97  98  94  95  89 
DTP1 97  97  99  96  96  88 
DTP3 94  94  96  90  92  81 
HepB3 94  94  96  90  92 
HepB_BD
Hib3 94  94  99  99  99 
MCV 96  98  99  99  99  76 
MCV2
PAB 94  94  93  93  86  80 
PCV3
Pol3 94  94  96  90  92  82 
Rota_last

Number of districts in the country 58  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 31
From 80 to 89% 9
From 50 to 79% 47
Less than 50% 14
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
HIB 6, 10, 14 weeks; Yes
IPV weeks;
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj Yes From July 2015
Rotavirus 10, 14 weeks; Yes From July 2014
TT 1st contact pregnancy or > 14 years; +1, +6 months; +1, +1 years; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2007-2011  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 58  58  58  58 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

System performance

Total Nº districts in country number 58  58  58  58 
Nº districts with DTP3 coverage >=80% number 23  28  32 
% of districts with DTP3 coverage >=80% From 0 to 100% 40  48  55  12  17  17  17 
Nº districts with measles (MCV1) coverage >=95% number 16  17  12   
% of districts with MCV1 coverage >=95% From 0 to 100% 28  29  21   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  No   

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 14       

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.